Fig. 2From: New insights into the important roles of phase seperation in the targeted therapy of lung cancerYAP/TAZ undergo LLPS, forming liquid condensates with their relative co-activators, enhanced transcriptional activity, leading to tumorigenesis.SNHG9 drives the liquid droplet formation of LATS1 and inhibits the Hippo pathway. NONO promotes TAZ LLPSBack to article page